Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FXR0906 in Severe Hypertriglyceridemia or Hypertriglyceridemia With ASCVD
NCT07889245Phase 2Not yet recruiting
- Sponsor
- Fosun Pharma
- Start
- Oct 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of FXR0906 in hypertriglyceridemia, sponsored by Fosun Pharma. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
FXR0906
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT07889245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07889245.